Log in to save to my catalogue

Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34 super(+) cells

Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34 super(+) cells

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_20436378

Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34 super(+) cells

Subjects

More information

Scope and Contents

Contents

Gene transfer has potential as a once-only treatment that reduces viral load, preserves the immune system and avoids lifetime highly active antiretroviral therapy. This study, which is to our knowledge the first randomized, double-blind, placebo-controlled, phase 2 cell-delivered gene transfer clinical trial, was conducted in 74 HIV-1-infected adul...

Alternative Titles

Full title

Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34 super(+) cells

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_20436378

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_20436378

Other Identifiers

ISSN

1078-8956

E-ISSN

1546-170X

DOI

10.1038/nm.1932

How to access this item